---
$id: https://graph.org.ai/products/commodity/51373301
$type: Product
source: UNSPSC
code: "51373301"
title: "Acetaminophen/dihydrocodeine/salicylamide"
class: "51373300"
classTitle: "Combination opioid analgesics"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Acetaminophen/dihydrocodeine/salicylamide

**UNSPSC Code**: 51373301
**Class**: [Combination opioid analgesics](Combination opioid analgesics.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS. The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. The European Medicines Agency schedules Acetaminophen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09611MIG. The World Health Organization schedules acetaminophen in its Anatomical Therapeutic Chemical (ATC) Classification. The second component of this combination drug is an opioid receptor agonist and opioid with the molecular formula C18H23NO3, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier N9I9HDB855, chemically known as 7, 8-dihydrocodeine but more generally known as dihydrocodeine, which bears U.S. National Institutes of Health Compound Identifier 3063. The European Medicines Agency schedules Dihydrocodeine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07138MIG. The term DIHYDROCODEINE is an International Non-Proprietary Name. The World Health Organization schedules dihydrocodeine in its Anatomical Therapeutic Chemical (ATC) Classification. The third component of this combination drug is a nonsteroidal antiinflammatory drug, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier EM8BM710ZC. The European Medicines Agency schedules Salicylamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10426MIG. Salicylamide generally arises in the molecular formula C7H7NO2. The term SALICYLAMIDE is an International Non-Proprietary Name or INN.

